CLASS II Device recall · Reported 24 Apr 2019 · FDA Enforcement Report

Tibial Total Ankle Prosthesis Tray, Size 3, Product No. LJU223T recalled

Integra LifeSciences is recalling Tibial Total Ankle Prosthesis Tray, Size 3, Product No. LJU223T, distributed in 26 states. The recall was initiated on 8 Mar 2019 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codes180894 181152
Quantity recalled2029

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1161-2019
FDA event ID
82377
Recalling firm
Integra LifeSciences, Plainsboro, NJ
Classification
Class II
Status
Terminated
Recall initiated
8 Mar 2019
FDA classified
16 Apr 2019
Reported
24 Apr 2019
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

8 Mar 2019Recall initiated by company
16 Apr 2019Classified by FDA+39 days
24 Apr 2019Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

The Salto Talaris and Integra XT Revision implant labelling was found to list an incorrect metallic coating material symbol on the metallic implant labels (box and inner pouch) and IFU

Product as listed by the FDA

Tibial Total Ankle Prosthesis Tray, Size 3, Product No. LJU223T

Where it was distributed

Distributors in AL, CA, CT, FL, GA, HI, IA, ID, KS, KY, MD, MI, MO, MT, NC, NE, NJ, NM, NY, OH, OK,PA, TX, VA, WA, and WI.

AlabamaCaliforniaConnecticutFloridaGeorgiaHawaiiIowaIdahoKansasKentuckyMarylandMichiganMissouriMontanaNorth CarolinaNebraskaNew JerseyNew MexicoNew YorkOhio

Questions about this recall

Is Tibial Total Ankle Prosthesis Tray, Size 3, Product No. LJU223T recalled?

Yes. Integra LifeSciences recalled Tibial Total Ankle Prosthesis Tray, Size 3, Product No. LJU223T on 8 Mar 2019. The recall is Class II and its status is Terminated. Recall number Z-1161-2019.

Why was it recalled?

The Salto Talaris and Integra XT Revision implant labelling was found to list an incorrect metallic coating material symbol on the metallic implant labels (box and inner pouch) and IFU

Which lots are affected?

180894 181152

Where was it sold?

Distributors in AL, CA, CT, FL, GA, HI, IA, ID, KS, KY, MD, MI, MO, MT, NC, NE, NJ, NM, NY, OH, OK,PA, TX, VA, WA, and WI.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Integra LifeSciences

All 246

Other Hip & Knee Implants recalls

All 3,097